Hydrostasis Selected as a Top 4 NIH-NHLBI SBIR Company at ACC Innovation Challenge
April 2022

WASHINGTON D.C., April 2022 -- Hydrostasis was honored to be one of the top four NIH-NHLBI SBIR awardees invited to present at the 2022 American College of Cardiology (ACC.22) Annual Meeting.

Our presentation was featured in the Future Hub, a showcase dedicated to the future of health technology and innovation. This dynamic space is designed to inform, educate, and inspire ACC.22 attendees by highlighting cutting-edge advancements in Digital Health, Medical Devices, and Educational Technology.

We’re proud to be recognized for our work in personalized hydration monitoring and to contribute to the conversation on next-generation solutions for cardiovascular care and beyond.

More from our blog